Arthur Levin

Arthur Levin, Ph.D., has been named to the strategic advisory board of Codexis, Inc., in California. Arthur is a founding member of Avidity Biosciences, a biopharmaceutical company committed to delivering a new class of RNA therapeutics called antibody oligonucleotide conjugates, and currently serves on its board of directors. He brings three decades of experience developing oligonucleotides to Codexis.